Print

THREE MAJOR OBJECTIVES

Ipsen leverages its technological and sales expertise, as well as its financial strength, to pursue profitable growth in three priority areas:

• growth in its four targeted therapeutic areas (oncology, endocrinology, neurology and hematology) to allow Ipsen to become a major player
• geographical expansion in larger markets, in particular in the USA
• optimization of its primary care products, through a selective investment strategy.